Compare · CRMD vs NEXT
CRMD vs NEXT
Side-by-side comparison of CorMedix Inc. (CRMD) and NextDecade Corporation (NEXT): market cap, price performance, sector, and recent activity on the wire.
Summary
- CRMD operates in Health Care, while NEXT operates in Utilities - the two are in different parts of the market.
- NEXT is the larger of the two at $1.88B, about 12.1x CRMD ($155.0M).
- Over the past year, CRMD is down 18.1% and NEXT is down 7.7% - NEXT leads by 10.4 points.
- NEXT has been more active in the news (3 items in the past 4 weeks vs 2 for CRMD).
- NEXT has more recent analyst coverage (14 ratings vs 7 for CRMD).
- Company
- CorMedix Inc.
- NextDecade Corporation
- Price
- $7.42+1.23%
- $7.08-4.71%
- Market cap
- $155.0M
- $1.88B
- 1M return
- +12.00%
- -3.54%
- 1Y return
- -18.06%
- -7.69%
- Industry
- Biotechnology: Pharmaceutical Preparations
- Oil & Gas Production
- Exchange
- AMEX
- NASDAQ
- IPO
- 2015
- News (4w)
- 2
- 3
- Recent ratings
- 7
- 14
CorMedix Inc.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. It primarily focuses on the development of its lead product candidate DefenCath/Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
NextDecade Corporation
NextDecade Corporation, a liquefied natural gas (LNG) development company, engages in the development activities related to the liquefaction and sale of LNG. It focusses on the development activities of Rio Grande LNG terminal facility located in the Port of Brownsville, southern Texas. The company is headquartered in Houston, Texas.
Latest CRMD
- SEC Form PRE 14A filed by CorMedix Inc.
- CorMedix to Participate in Needham Virtual Healthcare Conference
- Amendment: SEC Form SCHEDULE 13G/A filed by CorMedix Inc.
- CorMedix Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-K filed by CorMedix Inc.
- CorMedix Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026
- CorMedix to Participate in Upcoming Investor Conferences
- Chief Legal Officer Zelnick Kaufman Beth was granted 36,006 shares, increasing direct ownership by 15% to 269,108 units (SEC Form 4)
Latest NEXT
- SEC Form DEF 14A filed by NextDecade Corporation
- SEC Form 8-K filed by NextDecade Corporation
- NextDecade Announces Timing of First Quarter 2026 Investor Call
- SEC Form 4 filed by Beall Pamela K.M.
- TD Cowen reiterated coverage on NextDecade with a new price target
- NextDecade Provides Fourth Quarter 2025 Business Update
- NextDecade Announces Timing of Fourth Quarter 2025 Investor Call
- CapitalOne initiated coverage on NextDecade with a new price target
- Director Beall Pamela K.M. was granted 30,245 shares, increasing direct ownership by 447% to 37,007 units (SEC Form 4)
- Director Vrattos William C was granted 51,984 shares, increasing direct ownership by 196% to 78,517 units (SEC Form 4)